DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
3.130
-0.110 (-3.40%)
At close: Sep 8, 2026, 4:00 PM EDT
3.170
+0.040 (1.28%)
After-hours: Sep 8, 2026, 7:30 PM EDT

DNA X Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---93.6369.8354.57
Revenue Growth
---34.09%27.96%-14.72%
Gross Profit
---19.3211.626.41
Operating Income
-6.06-5.41-3.10.51-13.09-38
Net Income
-8.55-20.66-33.65-0.09-14.09-38.63
Earnings Per Share
-7.35-28.58-128.37-0.38-87.77-734.62
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.91.35.349.413.2111.23
Total Debt
2.45.07--0.210.21
Net Cash (Debt)
-1.5-3.765.349.41311.02
Net Cash Growth
---43.14%-27.71%17.98%-49.41%
Net Cash Per Share
-1.29-5.2120.3839.4581.00209.56

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.51-23.53-8.49-4.05-12.36-38.48
Capital Expenditures
---0.21-0.04-0.01-0.05
Free Cash Flow
-14.51-23.53-8.7-4.09-12.37-38.52
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---20.64%16.64%11.75%
Operating Margin
---0.55%-18.75%-69.64%
Pretax Margin
---0.30%-19.91%-70.48%
Profit Margin
----0.10%-20.17%-70.78%
FCF Margin
----4.37%-17.71%-70.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-6.286.2814.7027.4227.42
PS Ratio
---0.340.250.27